TRIPLE COMBINATION THERAPY FOR TREATING INFLAMMATORY BOWEL DISEASE

The invention features new a method for treating inflammatory bowel disease, including Crohn's Disease (CD) or ulcerative colitis in a human patient, comprising administering to a patient a combination therapy comprising an anti-α4β7 antibody, a TNFα antagonist, and an immunomodulator. L'i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	COLOMBEL, Jean-Frederic, LISSOOS, Trevor Warren
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention features new a method for treating inflammatory bowel disease, including Crohn's Disease (CD) or ulcerative colitis in a human patient, comprising administering to a patient a combination therapy comprising an anti-α4β7 antibody, a TNFα antagonist, and an immunomodulator. L'invention concerne une nouvelle méthode de traitement d'une maladie intestinale inflammatoire, dont la maladie de Crohn (CD) ou la rectocolite hémorragique chez un patient humain, comprenant l'administration au patient d'une polythérapie comprenant un anticorps anti-α4β7, un antagoniste de TNFα et un immunomodulateur.